GAFFX | SWLSX | GAFFX / SWLSX | |
Total Expense Ratio | 0.30 | 0.99 | 30% |
Annual Report Gross Expense Ratio | 0.30 | 1.00 | 30% |
Fund Existence | 8 years | 20 years | - |
Gain YTD | 5.197 | 2.705 | 192% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 306B | 507M | 60,355% |
Annual Yield % from dividends | 0.65 | 0.00 | - |
Returns for 1 year | 7.65 | 13.25 | 58% |
Returns for 3 years | 54.61 | 82.21 | 66% |
Returns for 5 years | 51.03 | 96.60 | 53% |
Returns for 10 years | N/A | 108.32 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
PASIX | 10.77 | -0.03 | -0.28% |
PACE Alternative Strategies A | |||
MRLOX | 18.51 | -0.15 | -0.80% |
BlackRock Global Allocation R | |||
OGIIX | 50.52 | -0.50 | -0.98% |
Invesco Global Opportunities R6 | |||
ECHSX | 12.96 | -0.14 | -1.07% |
Eaton Vance Worldwide Health Sci C | |||
GFVUX | 15.32 | -0.20 | -1.29% |
Goldman Sachs Focused Value R6 |